InvOpps GP IV, L.L.C.

InvOpps GP IV, L.L.C. is a declared insider of Oyster Point Pharma, Inc., with filings sourced from SEC (Form 4). Between 4 November 2019 and 3 January 2023, the trades on record add up to 8 filings.

Purchases make up the whole of the open-market record (4 purchases, €15.3M). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

The median purchase comes to €3.3M. Clusters matter here: 2 out of 4 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The record was last updated on 5 January 2023 with a transaction in Oyster Point Pharma, Inc. The last insider purchase was made public on 21 May 2020, 2,346 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.